Skip to main content
Smith & Nephew PLC

Smith & Nephew PLC

Search complete. 24 mentions across 13 episodes found for "Smith & Nephew PLC".

Sep 17, 2026

Marella FernandezHOST
42:43
Okay.
Marella FernandezHOST
42:44
Let's get to your next, uh, pick then, which is Smith & Nephew, S&N, uh, out of New York.
Marella FernandezHOST
42:50
Uh, this is a pharmaceutical company, I guess, but actually medical products?
Martin CobbGUEST
42:55
No, it's medical devices.
Martin CobbGUEST
43:39
And you've seen some pressures on the industry.
Martin CobbGUEST
43:41
Uh, Stryker's had an issue with a cyber hack, and so it's derated to about 20 times earnings.
Martin CobbGUEST
43:46
The Smith & Nephew's on about 12, 13 times respective earnings for a, a long-term secular grower.
Martin CobbGUEST
43:51
Also, they have an activist shareholder now on board.
Jerry EnnettGUEST
11:53
Uh, and then 20 to 25 that are W2s.
Jerry EnnettGUEST
11:56
And then we have a network of 1099s, um, that they might, they might be a Smith and Nephew rep, Zimmer rep,
Samuel AdeyinkaHOST
12:02
the
Jerry EnnettGUEST
12:03
Pew rep, uh, ortho development, Medacta United, um, probably like around, um, maybe a hundred of those that are covering cases every day.
Jerry EnnettGUEST
12:16
The United reps is going to get commissioned on our stuff too, because he's there.
Jerry EnnettGUEST
12:19
Right.
Jerry EnnettGUEST
12:19
So he's our 1099 across the room might be a striker or a Smith and nephew user.
Jerry EnnettGUEST
12:24
That's selling his implants to the surgeon and using ours and getting commissions.
Johnny CaffaroGUEST
1:32
Yeah, I mean, there's just always evolution of Jonny Cafero, right? Always growing, always expanding.
Johnny CaffaroGUEST
1:39
So right now I'm at Smith & Nephew, um, Orthopedics.
Johnny CaffaroGUEST
1:42
I'm the senior manager for the US for the hip revision portfolio, and I've been there almost a year now.
Johnny CaffaroGUEST
1:49
Um, and it's a blast.
Johnny CaffaroGUEST
3:00
I mean, um, that was a really fun post, um, to be able to announce that, because dude, I, I, for a long time after I left Stryker, it was smaller, like nonprofits and then a startup company with Redefined Surgery.
Jacob McLaughlinHOST
3:13
Mm-hmm.
Johnny CaffaroGUEST
3:14
And, um, like these companies, I wasn't there for a really long time and so it's like to be at Smith & Nephew for the last year and be like flourishing and enjoying it, it's, it's a world of a difference.
Jacob McLaughlinHOST
3:25
Yeah.
Johnny CaffaroGUEST
1:32
Yeah, I mean, there's just always evolution of Johnny Cafaro, right? Always growing, always expanding.
Johnny CaffaroGUEST
1:39
So right now, I'm at Smith & Nephew Orthopedics.
Johnny CaffaroGUEST
1:42
I'm the senior manager for the US for the hip revision portfolio.
Johnny CaffaroGUEST
1:47
And I've been there almost a year now.
Johnny CaffaroGUEST
3:04
Because, dude, for a long time after I left Stryker, it was smaller, like, nonprofits and then a startup company with redefined surgery.
Johnny CaffaroGUEST
3:14
And, like, these companies, I wasn't there for a really long time.
Johnny CaffaroGUEST
3:18
And so it's, like, to be at Smith & Nephew for the last year and be, like, flourishing and enjoying it, it's a world of a difference.
Jacob McLaughlinHOST
3:25
Yeah.
Samuel AdeyinkaHOST
11:59
Okay
Jerry EnnettGUEST
11:59
... um, that they might, they might be a Smith+Nephew rep, Zimmer rep-
Samuel AdeyinkaHOST
12:02
Yeah
Jerry EnnettGUEST
12:02
...
Alfred Atanda Jr.GUEST
29:30
So there'll be mortgage lenders, there'll be financial planners, there'll be legal folks, there'll be realtors.
Alfred Atanda Jr.GUEST
29:36
It's not as sexy as you would think, right? There's no Stryker or Smith & Nephew or Zimmer sponsoring it, but these are going to be events for the people so that they, you know, we train for 15, 20 years and we forget everything else about our lives.
Alfred Atanda Jr.GUEST
29:51
Just like we talked about whole child health.
Alfred Atanda Jr.GUEST
29:53
It's like whole doctor health.
Min KocherGUEST
32:21
And that was a big reason why I wanted to go to Stedman Hawkins because Dr. Hawkins was there and doing shoulder arthroscopy stabilization.
Min KocherGUEST
32:28
So, so it's something I did kind of dabble in and pick up a Smith and Nephew was in North Andover, and we worked on some instrumentation.
Min KocherGUEST
32:39
We had an early hip arthroscopy study group, and I thought this really could have some potential implications in the pediatric adolescent patient population.
Min KocherGUEST
32:51
And then over time, our original hip arthroscopies in the early 2000s was really debriding the labrum, taking out loose bodies, and then has evolved to labral repair and even reconstruction, understanding femoral acetabular impingement, being able to treat CAM and pincer impingement, now understanding more about instability and repairing the capsule or placating the capsule.
StephanieGUEST
14:38
And take out those things that could cause you lots of problems.
StephanieGUEST
14:42
And as a Canadian, I always thought my English was good enough until I hit Smith and Nephew.
StephanieGUEST
14:47
And then I became the FDA rep between countries and stuff because they realized and I also realized that the English of the FDA is not equal to english exactly so you have to watch out so
Monir El AzzouziHOST
15:00
exactly
David KustoffGUEST
1:45
Medical device makers I visited with Stryker.
David KustoffGUEST
1:47
I visited with Medtronic, with Smith & Nephew.
David KustoffGUEST
1:53
And they're all blowing and going.
David KustoffGUEST
1:56
That's good.
Allison BrownGUEST
33:12
And so that was our early source of capital.
Allison BrownGUEST
33:14
And Really, the goal at Ramon was to do a strategic partnership with one of the big wound care companies, a Smith & Nephew or a Coloplast or a company like that that had a massive global wound care portfolio.
Allison BrownGUEST
33:26
We made great headway.
Allison BrownGUEST
33:27
And I say we, largely Michael was the external face of the company.

3 more episodes mention Smith & Nephew PLC.

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.